Cyclin D1 Polymorphism and Expression in Patients with Squamous Cell Carcinoma of the Head and Neck
- 30 November 2001
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 159 (5) , 1917-1924
- https://doi.org/10.1016/s0002-9440(10)63038-6
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- A potential mechanism for fumonisin B 1 -mediated hepatocarcinogenesis: cyclin D1 stabilization associated with activation of Akt and inhibition of GSK-3β activityCarcinogenesis: Integrative Cancer Research, 2000
- Cyclin D1/PRAD1/BCL-1 alternative transcript [B] protein product in B-lymphoid malignancies with t(11;14)(q13;q32) translocationInternational Journal of Cancer, 1999
- Alternatively spliced forms of cyclin D1 modulate entry into the cell cycle in an inverse mannerOncogene, 1998
- Cancer Cell CyclesScience, 1996
- Clinical significance of cyclin D1 expression in patients with node-positive breast carcinoma treated with adjuvant therapyAnnals of Oncology, 1996
- Prognostic Factors for Head and Neck Tumor RecurrenceActa Oto-Laryngologica, 1995
- Cyclin D1 induction in breast cancer cells shortens G1 and is sufficient for cells arrested in G1 to complete the cell cycle.Proceedings of the National Academy of Sciences, 1994
- Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts.Genes & Development, 1993
- Potentially malignant lesions and conditions of the mouth and oropharynxEuropean Journal Of Cancer Prevention, 1993
- A novel cyclin encoded by a bcl1-linked candidate oncogeneNature, 1991